Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies

Reuters
02/05
<a href="https://laohu8.com/S/VVOS">Vivos Therapeutics</a> Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies

Vivos Therapeutics Inc., a leader in medical devices and healthcare services for breathing-related sleep disorders, has announced a collaboration with SoundHealth, a Silicon Valley health technology company specializing in AI-enabled allergy and sleep therapeutics. The partnership aims to expand access to SoundHealth’s FDA-cleared airway and sleep health technologies through Vivos’ extensive provider network. As part of the agreement, Vivos will act as a reseller of SoundHealth products, including the Sonu smartphone app, which uses voice biomarkers and facial scanning to monitor airway health. The collaboration leverages SoundHealth’s large craniofacial dataset and innovative technology to promote airway health awareness and improve non-invasive treatment options for sleep and allergy patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9649526-en) on February 05, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10